LOGIN  |  REGISTER
Chimerix

Progyny (NASDAQ: PGNY) Stock Quote

Last Trade: US$34.20 -0.77 -2.20
Volume: 356,880
5-Day Change: -3.66%
YTD Change: -8.02%
Market Cap: US$3.300B

Latest News From Progyny

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and RESOLVE : The National Infertility Association today announced a series of nationwide events to commemorate National Infertility Awareness Week (April 21-27, 2024). "National Infertility Awareness Week sheds light on the profound impact of infertility, promoting... Read More
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 1:30 P.M. Eastern Time. A... Read More
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Michael Sturmer, Progyny’s President, will participate in a fireside chat at Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024 at 10:15 A.M. Eastern Time. A live... Read More
NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, announced today that its Board of Directors has approved a share repurchase program to repurchase up to $100 million of its common stock. The program will be funded through available cash balances. Shares may be repurchased through open market repurchases, including... Read More
Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% Growth Achieves 49% Growth in Adjusted EBITDA to Record $187.1 Million Issues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a transformative fertility, family building and women's health benefits solution, today announced its... Read More
NEW YORK, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period and full year ended December 31, 2023 after the close of the market on Tuesday, February 27, 2024. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press... Read More
Vistia Health brings Progyny's comprehensive suite of fertility and family building services to its clients PHILADELPHIA , Jan. 17, 2024 /PRNewswire/ -- Vistia Health , a healthcare navigator supporting whole-person health journeys, today announced that it has selected Progyny, Inc. to be the preferred fertility and family building benefits provider for Vistia Health clients. Progyny, Inc (Nasdaq: PGNY) is a leading benefits... Read More
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced two newly created roles with the appointment of Katie Higgins as Chief Commercial Officer and Steven Leist as Chief Technology Officer. “We are excited to expand our executive team and welcome Katie and Steven to Progyny. Their expertise will further advance... Read More
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Progyny (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today announced that Pete Anevski, Progyny’s Chief Executive Officer, will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 8:15 A.M. Pacific Time / 11:15 A.M. Eastern Time. Following the presentation, Michael Sturmer, Progyny’s... Read More
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday,... Read More
Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year Period Raises Full Year Revenue and Earnings Guidance Strong Sales Season Produces 1.3 Million New Covered Lives NEW YORK, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced its... Read More
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, and The Broken Brown Egg , a nonprofit supporting BIPOC individuals and couples experiencing infertility, today launched the 2023 Awareness, Hope, and Activism (AHA) Grant™. Black women are twice as likely to suffer from infertility but are half as... Read More
NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended September 30, 2023 after the close of the market on Tuesday, November 7, 2023. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a... Read More
NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Progyny , Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced their nearly five-year partnership with Amazon has reached a milestone number of more than 30,000 individuals and families being supported on their family building journeys. Since 2019, Amazon has partnered with Progyny to deliver... Read More
NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the strategic expansion of its extensive managed reproductive health network to include specialized providers of menopause care. Progyny’s employer clients who elect to include this service of tailored perimenopause and menopause... Read More
Reports Record Quarterly Revenue of $279.4 Million, Reflecting 43% Growth Over the Prior Year Period Achieves Record Quarterly Operating Cash Flow of $76.0 Million Raises Full Year Revenue and Earnings Guidance Continuing to See Strong Employer Demand for Fertility and Family Building Solutions NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management... Read More
NEW YORK, July 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended June 30, 2023 after the close of the market on Thursday, August 3, 2023. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press... Read More
Quantum Health’s employee navigation and care coordination platform expands to include Progyny’s leading fertility and family-building solution. DUBLIN, Ohio / Jun 29, 2023 / Business Wire / Quantum Health , the leading consumer healthcare navigation and care coordination company, announced today it has partnered with Progyny, Inc. (Nasdaq: PGNY) as part of its launch of a new family-building benefits offering to help... Read More
NEW YORK, June 05, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies 2023 Healthcare Conference on Wednesday, June 7, 2023, at 2:00 P.M. Eastern Time.... Read More
Reports Record Quarterly Revenue of $258.4 Million, Reflecting 50% Growth Over the Prior Year Period Raises Full Year Revenue and Earnings Guidance Strong Demand Continues for Family Building Solutions as Affirmed by Healthy Utilization, Early Sales Activity and New Partnerships NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company... Read More
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, Mark Livingston, Chief Financial Officer, and Michael Sturmer, President, will participate in a fireside chat at the Bank of America Health Care Conference 2023 on Tuesday, May 9,... Read More
NEW YORK, April 24, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended March 31, 2023 after the close of the market on Monday, May 8, 2023. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press... Read More
NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, and Fertility Matters Canada, a national fertility patient-focused organization, today announced both organizations will be co-hosting an event to garner support for increased access to family building care. The event will overlook the CN Tower,... Read More
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, in its capacity as an official partner for National Infertility Awareness Week 2023, and RESOLVE: The National Infertility Association today announced both organizations will light the top of the Empire State Building in orange, the official color... Read More
NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the appointment of Janet Choi, M.D., as the company's Chief Medical Officer. Dr. Choi brings more than 20 years of experience in the field as a board-certified specialist in Obstetrics and Gynecology and in Reproductive Endocrinology.... Read More
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, announced today its partnership with Children’s Hospital Association (CHA), a national voice for more than 220 children’s hospitals with over two million covered lives. Progyny’s selection as CHA’s preferred and exclusive partner means all... Read More
NEW YORK, March 20, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 2:15... Read More
NEW YORK, March 14, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced the expansion of its provider network to include reproductive urologists (RU). Patients with Progyny’s comprehensive and equitable solution will now have convenient access to high-quality urological care, in addition to the existing... Read More
NEW YORK, March 01, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) a leading benefits management company specializing in fertility and family building benefits solutions, today announced a partnership with the National Basketball Association’s Detroit Pistons . Through this partnership, the Detroit Pistons will have access to equitable and comprehensive family building care that its diverse workforce requires. The... Read More
Reports Full Year Revenue of $786.9 Million, Reflecting 57% Growth Reports Record Quarterly Revenue and Operating Cash Flow of $214.3 Million and $51.5 Million, Respectively Issues Financial Guidance for 2023, Anticipates Crossing $1 Billion Revenue Milestone NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility... Read More
NEW YORK, Feb. 13, 2023 (GLOBE NEWSWIRE) - - Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period and full year ended December 31, 2022 after the close of the market on Monday, February 27, 2023. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time)... Read More
Anticipates Results to be at the High-End of its Previously Provided Financial Guidance Anticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that the Company is... Read More
Astria Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB